Abstract
Ca channel blocker (CCB) is widely used as an anti-hypertensive and anti-ischemic heart disease drug in Japan. CCB or angiotensin receptor antagonist (ARB) is selected as a first line anti-hypertensive drug. However, mono-therapy is often insufficient and combination therapy is needed to achieve the adequate blood pressure control. Hypertensive patients are also sometimes combined with dyslipidemia. In these reasons, a single pill combination of CCB and ARB or statin play an important role in hypertensive and anti-atherosclerotic therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
